-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/children-special-needs-transition_research-protocol.pdf
October 01, 2013 - children-special-needs-transition-protocol-131003
Evidence-based Practice Center Te c h n i c a l B rie f P r o t o co l
Project Title: Transitions Care for Children With Sp…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
May 19, 2020 - Assessing Applicability: We will consider elements of the PICOTS framework
when evaluating the applicability
-
effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
October 12, 2020 - o The reviewer also suggested evaluating colorectal cancer (CRC) rates found
on colonoscopy by country
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_branson.pdf
October 13, 2011 - <#> Significant Work. Extraordinary People. SRA.
Outreach to Patient and
Consumer Representatives
October 13, 2011
Carolyn Branson, Manager
Consumer Reviewer Administration
2
Topics
• Who are they?
• What characteristics do they share?
• How can you identify the “right” perso…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2012.pdf
January 01, 2012 - The Facilitation Primer: Strategies, Tools & Considerations to Get You Started
The Facilitation Primer
Strategies, Tools & Considerations to Get
You Started
The Effective Health Care Program
Revised January 2012
This guide was created by the Scientific Resource Center at the Oregon Eviden…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - As suggested in the public comments, we will consider when evaluating
efficacy data whether patients … biologic agents and systemic nonbiologic agents (between-class comparisons) or phototherapy
when evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
March 01, 2011 - performance, such as
sensitivity and specificity compared with a given reference
standard, and focus on evaluating … Consistent with
this review, prior systematic reviews47,48 have reported
few or no comparative studies evaluating … Six RCTs evaluating
CCTA were multicenter studies; five were in single-center
sites.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
January 01, 2010 - A comprehensive review evaluating the benefits and
harms of screening for MRSA carriage will identify … The cluster RCT is increasingly recognized as the
optimal design for testing and evaluating the impact
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults_research-protocol.pdf
December 20, 2011 - Key informants affirmed that differences in case mix across settings must
be considered when evaluating … We will not
be evaluating any other sub-groups for sub-analysis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - focus on
features of designs rather than on design labels when assessing studies for inclusion and
evaluating … from
efficacy to effectiveness.19 These changes in the focus of EPC work heighten the urgency for
evaluating … focused on systems for grading
evidence,23,24 and a variety of approaches have been developed for evaluating … other approaches to defining study
designs or design features that are important to consider when evaluating … Evaluating
non-randomised intervention studies. Health
Technol Assess 2003;7(27).
8. Black N.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
March 01, 2011 - Apart from evaluating the comparative effectiveness and safety of pharmacologic
prophylaxis, in our … The length of the evaluation period will be considered when evaluating the benefits and risks (short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
October 01, 2020 - unpublished studies from
1999 to 2002 (i.e., going beyond the 2004 review3), while also explicitly evaluating … Assessing Applicability: We will consider elements of the PICOTS framework when
evaluating the applicability
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
January 01, 2005 - What do we know about how evidence of harm and benefit is communicated in other countries?
What do we know about how evidence of harm and benefit is communicated in other countries?
Valerie King MD, MPH and David Hickam MD, MPH
John M. Eisenberg Clinical Decisions and Communications Science Center
Oregon Health &…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - We
excluded the one crossover study
evaluating ustekinumab, so this
point is moot. … Recommendation: Please consider adding in and evaluating two studies to this review
regarding infliximab … As a team, we decided on 10%
as clinically meaningful prior to
evaluating the evidence. … We clearly state we are
evaluating all 3 anti-TNFs. … None of the studies evaluating
corticosteroids reported on
opportunistic infections, so we
can’t make
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
May 01, 2017 - Key Question 2a
There are no prospective planned comparisons evaluating
whether the presence of middle
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nitric-oxide_research-protocol.pdf
September 06, 2016 - We will evaluate potential publication bias by evaluating
funnel plots symmetry and using statistical
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
August 18, 2016 - ADHD-Update-protocol-160818
Source: www.effectivehealthcare.ahrq.gov
Published online: August 18, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Attention Deficit Hyperactivity Disorder (ADHD)
Initial publication date if applicable: Nov 25, 2015
Amendment Date(s) if applicabl…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - Effective Health Care
Topic Number(s): 0041
Document Completion Date: 6-2-09
1
Results of Topic Selection Process & Next Steps
Clostridium difficile-associated disease (CDAD) will go forward for refinement as a comparative
effectiveness or effectiveness review. The scope of this topic, includi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
September 01, 2008 - different injection patterns and glucose testing
depending on the type of medication regimen
prescribed, evaluating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - As there are no studies evaluating effects
of using urinary biomarkers for diagnosis or surveillance … base is that few trials reported effects on progression
or mortality, and instead mostly focused on evaluating